EP2040757 - NEW PROTEIN CONJUGATES AND METHODS FOR THEIR PREPARATION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 27.11.2015 Database last updated on 02.11.2024 | Most recent event Tooltip | 27.11.2015 | Withdrawal of application | published on 30.12.2015 [2015/53] | Applicant(s) | For all designated states Novo Nordisk Health Care AG Thurgauerstrasse 36/38 8050 Zürich / CH | [2013/15] |
Former [2009/14] | For all designated states Novo Nordisk Health Care AG Andreasstrasse 15 8050 Zürich / CH | Inventor(s) | 01 /
DÖRWALD, Florencio Zaragoza Bäretstrasse 2 CH-3930 Visp / CH | [2009/18] |
Former [2009/14] | 01 /
DÖRWALD, Florencio Zaragoza No̸ddelunden 22 DK-2765 Smo̸rum / DK | Representative(s) | Winther, Kamilla Novo Nordisk A/S Corporate Patents Novo Allé 2880 Bagsvaerd / DK | [2009/14] | Application number, filing date | 07802373.6 | 05.07.2007 | [2009/14] | WO2007EP56819 | Priority number, date | EP20060116776 | 07.07.2006 Original published format: EP 06116776 | [2009/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008003750 | Date: | 10.01.2008 | Language: | EN | [2008/02] | Type: | A2 Application without search report | No.: | EP2040757 | Date: | 01.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application. | [2009/14] | Search report(s) | International search report - published on: | EP | 20.03.2008 | Classification | IPC: | A61K47/48, C07K14/43 | [2009/14] | CPC: |
C07K14/61 (EP,KR,US);
A61K38/27 (KR);
A61K47/60 (EP,US);
A61P13/12 (EP);
A61P19/00 (EP);
A61P25/30 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
A61P5/06 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/14] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | NEUE PROTEINKONJUGATE UND HERSTELLUNGSVERFAHREN | [2009/14] | English: | NEW PROTEIN CONJUGATES AND METHODS FOR THEIR PREPARATION | [2009/14] | French: | NOUVEAUX CONJUGUÉS DE PROTÉINES ET LEURS PROCÉDÉS DE PRÉPARATION | [2009/14] | Entry into regional phase | 09.02.2009 | National basic fee paid | 09.02.2009 | Designation fee(s) paid | 09.02.2009 | Examination fee paid | Examination procedure | 09.02.2009 | Examination requested [2009/14] | 18.01.2011 | Despatch of a communication from the examining division (Time limit: M04) | 26.04.2011 | Reply to a communication from the examining division | 06.10.2014 | Despatch of a communication from the examining division (Time limit: M06) | 13.04.2015 | Reply to a communication from the examining division | 25.11.2015 | Application withdrawn by applicant [2015/53] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.01.2011 | Fees paid | Renewal fee | 31.07.2009 | Renewal fee patent year 03 | 02.08.2010 | Renewal fee patent year 04 | 01.08.2011 | Renewal fee patent year 05 | 31.07.2012 | Renewal fee patent year 06 | 31.07.2013 | Renewal fee patent year 07 | 31.07.2014 | Renewal fee patent year 08 | 31.07.2015 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US4179337 (DAVIS FRANK F [US], et al) [X] 1-20 * the whole document * * example XII *; | [Y]WO9826747 (TERMAN DAVID S [US]) [Y] 1-20* page 50 *; | [X]WO02055532 (MAXYGEN APS [DK], et al) [X] 1-20 * page 6 - page 7 *; | [X]US6566506 (GREENWALD RICHARD B [US], et al) [X] 1-20 * columns 9,13; claim - *; | [X]WO03044056 (PHARMACIA CORP [US], et al) [X] 1-20 * the whole document * * examples 1-17 *; | [X]WO2005035553 (NOVO NORDISK AS [DK], et al) [X] 1-20 * page 82 - page 102 * * the whole document *; | [Y]EP1548016 (JAPAN SCIENCE & TECH AGENCY [JP], et al) [Y] 1-20 * the whole document *; | [Y] - ZALIPSKY S, "FUNCTIONALIZED POLY(ETHYLENE GLYCOL) FOR PREPARATION OF BIOLOGICALLY RELEVANT CONJUGATES", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, (1995), vol. 6, no. 2, ISSN 1043-1802, pages 150 - 165, XP002068523 [Y] 1-20 * the whole document * * page 152, column R, paragraph L * DOI: http://dx.doi.org/10.1021/bc00032a002 | Examination | WO2005123140 | - QIAN Y ET AL, "Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, (19991201), vol. 7, no. 12, doi:10.1016/S0968-0896(99)00252-7, ISSN 0968-0896, pages 3011 - 3024, XP002515932 DOI: http://dx.doi.org/10.1016/S0968-0896(99)00252-7 | - Xiaoxia Wen ET AL, "Improved Radiolabeling of PEGylated Protein: PEGylated Annexin V for Noninvasive Imaging of Tumor Apoptosis", Cancer Biotherapy & Radiopharmaceuticals, (20031001), vol. 18, no. 5, doi:10.1089/108497803770418364, ISSN 1084-9785, pages 819 - 827, XP055143315 DOI: http://dx.doi.org/10.1089/108497803770418364 |